| Debruin Medical Center A.p.c. | |
|
9352 Madison Ave Ste. One Orangevale CA 95662-4968 | |
| (916) 989-2929 | |
| (916) 989-0322 |
| Full Name | Debruin Medical Center A.p.c. |
|---|---|
| Speciality | Family Medicine |
| Location | 9352 Madison Ave, Orangevale, California |
| Authorized Official Name and Position | Mark Ike Debruin (OWNER) |
| Authorized Official Contact | 9169892929 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Debruin Medical Center A.p.c. 9352 Madison Ave Ste. One Orangevale CA 95662-4968 Ph: (916) 989-2929 | Debruin Medical Center A.p.c. 9352 Madison Ave Ste. One Orangevale CA 95662-4968 Ph: (916) 989-2929 |
| NPI Number | 1104095975 |
|---|---|
| Provider Enumeration Date | 02/26/2008 |
| Last Update Date | 02/26/2008 |
| Medicare PECOS PAC ID | 8022179142 |
|---|---|
| Medicare Enrollment ID | O20081209000025 |
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
Scientists at the Helmholtz Zentrum München have examined health insurance data of more than 300,000 people with diabetes in Germany.
A new study by researchers at Imperial College London has identified a way in which Salmonella bacteria, which cause gastroenteritis and typhoid fever, counteract the defence mechanisms of human cells.
Patients with asthma have chronic lung inflammation that results in sporadic narrowing of the airways and difficulty breathing. Symptoms and severity are variable among individuals; however, the cells and inflammatory factors that trigger asthmatic events have been fairly well characterized and are similar regardless of the asthma-inducing stimuli.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104095975 | NPI | - | NPPES |
| 00AX55790 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20A5579 (California) | Primary |
| Provider Name | Mark I Debruin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1154327518 PECOS PAC ID: 2567523681 Enrollment ID: I20081212000345 |
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
Scientists at the Helmholtz Zentrum München have examined health insurance data of more than 300,000 people with diabetes in Germany.
A new study by researchers at Imperial College London has identified a way in which Salmonella bacteria, which cause gastroenteritis and typhoid fever, counteract the defence mechanisms of human cells.
Patients with asthma have chronic lung inflammation that results in sporadic narrowing of the airways and difficulty breathing. Symptoms and severity are variable among individuals; however, the cells and inflammatory factors that trigger asthmatic events have been fairly well characterized and are similar regardless of the asthma-inducing stimuli.
› Verified 1 days ago
News Archive
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
Scientists at the Helmholtz Zentrum München have examined health insurance data of more than 300,000 people with diabetes in Germany.
A new study by researchers at Imperial College London has identified a way in which Salmonella bacteria, which cause gastroenteritis and typhoid fever, counteract the defence mechanisms of human cells.
Patients with asthma have chronic lung inflammation that results in sporadic narrowing of the airways and difficulty breathing. Symptoms and severity are variable among individuals; however, the cells and inflammatory factors that trigger asthmatic events have been fairly well characterized and are similar regardless of the asthma-inducing stimuli.
› Verified 1 days ago
Orangevale Family Medical Clinic, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8864 Greenback Ln, Suite B, Orangevale, CA 95662 Phone: 916-988-2900 Fax: 916-988-2990 | |
Advanced Practice Primary Care A Registered Nursing Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9267 Greenback Ln, Suite C2, Orangevale, CA 95662 Phone: 916-539-1449 Fax: 888-990-1397 | |
American River Urgent Care, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9490 Madison Ave Ste 100, Orangevale, CA 95662 Phone: 916-549-3973 | |
Wellness Chiropractic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9352 Madison Ave Ste 3, Orangevale, CA 95662 Phone: 916-987-0133 Fax: 916-987-0134 |